ISSAQUAH, Wash.--(BUSINESS WIRE)--BaroPace Inc. announces its Phase I first-in-human trial of PressurePace TM, its patent-pending pacemaker control algorithm for the treatment of heart failure with ...

Panelists discuss how effective heart failure management requires collaborative care across multiple specialties (primary care, cardiology, endocrinology, nephrology) with advanced practice providers ...

SAN FRANCISCO, CA, UNITED STATES, September 24, 2025 /EINPresswire.com/ -- RhythmScience, a leader in cardiac data management solutions, today announced it has ...

BORDEAUX, France--(BUSINESS WIRE)--FineHeart, a clinical-stage MedTech company developing innovative medical devices for heart failure, has achieved a major milestone in its "First in Human" study, ...

Panelists discuss how heart failure creates a massive economic burden of approximately $30 billion annually (expected to reach $70 billion to $80 billion by 2030), driven by hospitalizations, ...

Duke-NUS scientists and their collaborators have discovered a potential new treatment for heart failure with preserved ejection fraction (HFpEF), a type of heart disease that is notoriously difficult ...

Adults who have heart failure with a left ventricular ejection fraction of 40% or more face a high risk of hospitalization for heart failure and cardiovascular death. People who have heart failure ...

A multicenter study has identified a potential new treatment for acute heart failure, a leading cause of hospitalization and death. A multicenter study led by Vanderbilt University Medical Center ...

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

Advanced heart failure is when heart failure progresses to the most severe stage. When you have advanced heart failure, your blood pressure, blood flow, kidney and liver function, exercise capacity, ...